Exact Sciences Corp.

First New Breast Implant Since 2013 Receives FDA Premarket Approval Motiva is the first new breast implant to receive US Food and Drug Administration premarket approval since 2013, according to Estab

Exact Sciences Corp. announced today encouraging data from an ongoing colorectal cancer trial showing that its blood-based test can detect advanced precancerous lesions and growing tumors. The findin

It has been several years since Medtronic has not topped the annual Medtech 100 ranking of global medical device, diagnostic and digital health companies by revenues. But that was the outcome after

Diagnostic firm Genomics Health, a subsidiary of Exact Sciences Corp. , agreed to pay $32.5m to resolve allegations it had filed Medicare claims for some cancer tests. A North Carolina lab owner was